DE3785157T2 - Verfahren zur herstellung von toxoid. - Google Patents

Verfahren zur herstellung von toxoid.

Info

Publication number
DE3785157T2
DE3785157T2 DE87905002T DE3785157T DE3785157T2 DE 3785157 T2 DE3785157 T2 DE 3785157T2 DE 87905002 T DE87905002 T DE 87905002T DE 3785157 T DE3785157 T DE 3785157T DE 3785157 T2 DE3785157 T2 DE 3785157T2
Authority
DE
Germany
Prior art keywords
toxoid
producing
toxin
treating
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87905002T
Other languages
English (en)
Other versions
DE3785157D1 (de
Inventor
Ronald D Sekura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3785157D1 publication Critical patent/DE3785157D1/de
Publication of DE3785157T2 publication Critical patent/DE3785157T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE87905002T 1986-06-16 1987-06-04 Verfahren zur herstellung von toxoid. Expired - Lifetime DE3785157T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/874,637 US4762710A (en) 1986-06-16 1986-06-16 Novel method of preparing toxoid by oxidation and metal ions
PCT/US1987/001277 WO1987007507A1 (en) 1986-06-16 1987-06-04 Method of preparing toxoid

Publications (2)

Publication Number Publication Date
DE3785157D1 DE3785157D1 (de) 1993-05-06
DE3785157T2 true DE3785157T2 (de) 1993-11-04

Family

ID=25364220

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87905002T Expired - Lifetime DE3785157T2 (de) 1986-06-16 1987-06-04 Verfahren zur herstellung von toxoid.

Country Status (14)

Country Link
US (1) US4762710A (de)
EP (1) EP0269729B1 (de)
JP (1) JP2617500B2 (de)
KR (1) KR960010834B1 (de)
CN (1) CN1033003C (de)
AT (1) ATE87486T1 (de)
AU (1) AU604497B2 (de)
CA (1) CA1302883C (de)
DE (1) DE3785157T2 (de)
ES (1) ES2006763A6 (de)
GR (1) GR870917B (de)
IL (1) IL82825A (de)
WO (1) WO1987007507A1 (de)
ZA (1) ZA874064B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032398A (en) * 1986-08-01 1991-07-16 Kaslow Harvey R Selective modification of the catalytic subunit of pertussis toxin
US5165927A (en) * 1986-08-01 1992-11-24 University Of Southern California Composition with modified pertussis toxin
SE455946B (sv) * 1986-10-20 1988-08-22 Trion Forskning & Utveckling Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
AU631351B2 (en) * 1988-04-20 1992-11-26 Massachusetts Health Research Institute, Inc. (Mhri) Pertussis toxoid vaccine
AP8900132A0 (en) * 1988-07-22 1991-01-14 Smithkline Biolog Bordetella pertussis vaccine
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
EP0485652A1 (de) * 1990-11-14 1992-05-20 Theurer, Karl E., Prof.Dr.med. Verfahren zur Herstellung von Impfvaccinen gegen Krankheitserreger
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
EP0834322A3 (de) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Vakzine zur Behandlung von Mycosen
AU2003239773A1 (en) * 2002-06-28 2004-01-19 Novozymes A/S Preparation of vaccines
WO2008039171A2 (en) * 2005-08-08 2008-04-03 Oregon Health & Science University Inactivating pathogens with hydrogen peroxide for vaccine production
WO2021001540A1 (en) 2019-07-04 2021-01-07 Proxi Biotech Aps Detoxification of proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097141A (en) * 1959-02-26 1963-07-09 Kidwell Elizabeth N Wilcox Immunological method
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4058599A (en) * 1973-02-24 1977-11-15 Bayer Aktiengesellschaft Ethyleneimine inactivated organisms
DE2340911A1 (de) * 1973-08-13 1975-05-07 Behringwerke Ag Tetanus-antigen und verfahren zu seiner herstellung
CA1083508A (fr) * 1975-11-13 1980-08-12 Jacques Grange Supports porteurs de chaines laterales, procedes d'obtention de ces supports, procedes de fixation de composes organiques comportant un residu glucidique sur lesdits supports, produits et reactifs resultant de ladite fixation chimique
US4172126A (en) * 1976-11-08 1979-10-23 Sankyo Company Limited Method for the inactivation of microbial toxins and attenuation of vaccines
US4256732A (en) * 1978-08-15 1981-03-17 Research Corporation Modified grass pollen antigens
JPS55118420A (en) * 1979-03-07 1980-09-11 Sankyo Co Ltd Preparation of improved vaccine for hooping cough
US4314993A (en) * 1980-04-04 1982-02-09 Smithkline-Rit Immunogenic E. coli ST enterotoxin derivatives and compositions containing them
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.

Also Published As

Publication number Publication date
CN87104279A (zh) 1988-01-20
GR870917B (en) 1987-10-15
ES2006763A6 (es) 1989-05-16
EP0269729A1 (de) 1988-06-08
AU7804787A (en) 1988-01-11
CN1033003C (zh) 1996-10-16
JP2617500B2 (ja) 1997-06-04
KR880701109A (ko) 1988-07-25
KR960010834B1 (ko) 1996-08-09
CA1302883C (en) 1992-06-09
IL82825A0 (en) 1987-12-20
EP0269729B1 (de) 1993-03-31
ATE87486T1 (de) 1993-04-15
WO1987007507A1 (en) 1987-12-17
DE3785157D1 (de) 1993-05-06
IL82825A (en) 1992-05-25
EP0269729A4 (de) 1988-10-06
US4762710A (en) 1988-08-09
JPH01500354A (ja) 1989-02-09
ZA874064B (en) 1988-04-27
AU604497B2 (en) 1990-12-20

Similar Documents

Publication Publication Date Title
DE3785157T2 (de) Verfahren zur herstellung von toxoid.
DE3750176D1 (de) Impfstoff und verfahren zur herstellung.
DE68902575D1 (de) Verfahren zur herstellung von dihydroxybenzolen.
AT375378B (de) Verfahren zur herstellung von 4'-deoxydaunorubicin
ATE3866T1 (de) Verfahren zur herstellung einer kollagenloesung, eine solche loesung sowie ihre verwendung.
DE68906948T2 (de) Verfahren zur herstellung von nitrilen oder oxiden.
DE3883206D1 (de) Arzneistoff enthaltende fettemulsion des typs "kurz vor gebrauch hergestellt" sowie verfahren zur herstellung einer arzneihaltigen fettemulsion.
DE3789586D1 (de) Verfahren zum Herstellen eines Verkleidungsteiles sowie danach hergestelltes Verkleidungsteil.
EP0202947A3 (de) Impfstoffproduktion
ATE422900T1 (de) Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält
DE3774801D1 (de) Verfahren zur herstellung von aromatischen ether- und thioetherverbindungen.
DE3771846D1 (de) Verfahren zur herstellung von carbinolderivaten.
DE3765611D1 (de) Verfahren zur herstellung eines feinkoernig rekristallisierten bleches.
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
DE3770952D1 (de) Verfahren zur herstellung von hydroxylaminen.
ATE93729T1 (de) Extrakte der neriumspezies, verfahren zu deren herstellung und anwendung davon.
AT358163B (de) Verfahren zur herstellung detoxifizierter zubereitungen von cytostatika
DE68916805D1 (de) Verfahren zur herstellung von tocopherolen.
DE3766046D1 (de) Verfahren zur herstellung von isopropylakohol und tertiaeren c4-bis c5-alkoholen.
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
DE3588014D1 (de) Verfahren zur herstellung bissilylierter 3-iodmethylcephalosporinderivaten.
DE59108700D1 (de) Verfahren zur herstellung von 17-oxosteroiden
DE3775630D1 (de) Verfahren zur herstellung eines gemisches von 1-amino-2-chlor-4-hydroxyanthrachinon und 1-amino-2-brom-4-hydroxyanthrachinon.
DE3880903D1 (de) Herstellungsverfahren eines cycloalkanols.
DE3763312D1 (de) Verfahren zur herstellung von hexaalkyldisilan.